1. Home
  2. PXED vs CTMX Comparison

PXED vs CTMX Comparison

Compare PXED & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$29.91

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
CTMX
Founded
1976
2008
Country
United States
United States
Employees
3400
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
977.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PXED
CTMX
Price
$29.91
$3.76
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$44.29
$12.10
AVG Volume (30 Days)
71.6K
2.8M
Earning Date
04-07-2026
05-08-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.49
$7.61
P/E Ratio
$11.20
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$23.52
$1.72
52 Week High
$38.19
$8.21

Technical Indicators

Market Signals
Indicator
PXED
CTMX
Relative Strength Index (RSI) 53.45 39.49
Support Level $28.40 $3.39
Resistance Level $30.85 $3.91
Average True Range (ATR) 1.37 0.20
MACD -0.01 0.00
Stochastic Oscillator 57.47 39.76

Price Performance

Historical Comparison
PXED
CTMX

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: